Newpath Management
Signal active
Investment Firm
Overview
Newpath Partners, LP is a life science venture firm dedicated to excellent science and to forming partnerships based on trust and a shared vision.
Highlights
Founded
2018
Industry
Employees
1-10
Investment
18
Lead Investment
7
Exits
2
Stages
Late Stage Venture, Early Stage Venture, Seed
Investor Type
Private Equity Firm, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Newpath Management, established in 2018 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed investments across Biotechnology, Life Science, Health Care, Therapeutics, Venture Capital, FinTech, Biopharma, Financial Services, Finance, Business Development. The organization boasts a portfolio of 17 investments, with an average round size of $137.8M and 2 successful exits. Their recent investments include Autobahn Therapeutics, Canaan Partners, ARCH Venture Partners, Insight Partners, Section 32. The highest investment round they participated in was $249.0B. Among their most notable exits are Autobahn Therapeutics and Canaan Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Newpath Management has made 18 investments. Their most recent investment was on Jul 24, 2024, when Autobahn Therapeutics raised $100.0M.
Newpath Management has made 7 diversity investments. Their most recent diversity investment was on Apr 26, 2023, when Orbital Therapeutics raised $270.0M.
investments
18
Diversity investments
7
Lead investments
7
Number of exits
2
Investments
18
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Sep 19, 2023 | Magnet Biomedicine | Biotechnology | 50.0M |
| Sep 25, 2023 | Nvelop Therapeutics | Biotechnology | 100.0M |
| Apr 18, 2024 | Metsera | Health Care | 290.0M |
| Jul 24, 2024 | Autobahn Therapeutics | Biotechnology | 100.0M |
Exits
2
Funding Timeline
Funding rounds
18
Investors
0
Funds
2
Funding Rounds
18
Newpath Management has raised 18 rounds. Their latest funding was raised on Jul 24, 2024 from a Series C - Autobahn Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Sep 19, 2023 | Series A - Magnet Biomedicine | - | 50.0M | - |
| Sep 25, 2023 | Seed Round - Nvelop Therapeutics | - | 100.0M | - |
| Apr 18, 2024 | Series A - Metsera | - | 290.0M | - |
| Jul 24, 2024 | Series C - Autobahn Therapeutics | - | 100.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.